Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,180.6
38.9 (1.24%)

 

  • STI Straits Times Index
    3,180.6
    38.9 (1.24%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,512.9
    -2.5 (-0.16%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,315.3
    841.4 (3.30%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,411.7
    50.1 (1.49%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,782.4
    200.8 (0.73%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,120.7
    32.2 (0.53%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,159.2M
  • Value: 1,470.4M
  • Rise: 205
  • Fall: 137
  • Unch: 419

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
GKE0.153-0.008
Golden Agri-Res0.235+0.020
CapAllianz0.003-
Abundance Intl0.042-
Singtel2.280+0.050
Shen Yao0.007+0.001
RH PetroGas0.182+0.010
ISDN0.780+0.070
Sembcorp Marine0.108-0.002
Geo Energy Res0.260+0.015

World Indices

World Indices
Name Last Change
Nasdaq 14,762.6 +102.0
HSI 26,315.3 +841.4
HSCEI 9,415.7 +344.6
Jakarta 6,120.7 +32.2
Nikkei 225 27,782.4 +200.8
SSE Comp 3,411.7 +50.1
Shanghai A 3,575.8 +52.6
Shanghai B 256.1 +1.6
KOSPI 3,242.7 +5.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

HARTA HARTALEGA HOLDINGS BHD
Quotes 15 Minutes Delayed. Updated at 29 Jul 2021 16:59
Last (MYR): 7.150 Change: -0.190 High: 7.350 Remarks: s
Remarks legend:
RemarksDescriptionRemarksDescription
IOrder entry forbiddenAOrder entry authorized
GFrozenSSuspended
RReservedsShort selling available
[x]Exclude dividend[c] Cum dividend
Change (%): -2.59 Low: 7.150
Open 7.340 Yesterday's Close 7.340
Buy Price 7.140 Sell Price 7.150
Buy Volume ('00) 6 Sell Volume ('00) 769
Cumulative Volume ('00) 24,186 Cumulative Value 17,445,101
Click to show Stock Prices chart

Key Statistics

EPS (MYR) a 0.84389 Trailing EPS (MYR) e 0.84389 NAV (MYR) b 1.4550
PE a 8.473 Trailing PE f 8.473 Price / NAV b 4.9141
Dividend (MYR) d - Cash In Hand (MYR) g 0.7805 Issued & Paid-up Shares c 3,419,162,000
Dividend Yield (%) d - Price / Cash In Hand g 9.161 Treasury Shares h 8,445,000
Beta - 75 Daysi 1.789 R-Squared - 75 Days(%)i 11.66 Market Cap (M) 24,447.008
Beta - 500 Daysi 1.024 R-Squared - 500 Days (%)i 9.92 Enterprise Value (M) 22,149.190
Piotroski F Score 9 Exchange Code 5168 Par Value ( $ ) n.a.
52 Weeks Volatility (%) 55.77 6-Month VWAP 9.515 Free Float (%) 44.0
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Medical Specialties
Index Components BM HEALTH CARE / FTSE Bursa Malaysia EMAS Index / FTSE Bursa Malaysia EMAS Shariah Index / FTSE Bursa Malaysia Hijrah Shariah Index / FTSE Bursa Malaysia KLCI Index / FTSE Bursa Malaysia Top 100 Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 01 Jun 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 01 Jun 2021.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference HARTA Bursa 24,447.008 8.473 8.473 4.9141 -
Industry HEALTH CARE EQUIPMENT & SERVICES Bursa 9,369.191 11.803 4.180 4.5242 1.896
Medical Specialties Bursa 10,888.472 12.679 4.442 4.0139 1.474
Index BM HEALTH CARE Bursa 8,043.007 19.866 7.149 3.1571 1.412
FTSE Bursa Malaysia EMAS Index Bursa 5,112.219 36.482 23.963 1.2942 2.623
FTSE Bursa Malaysia EMAS Shariah Index Bursa 4,490.342 37.803 19.825 1.5291 2.324
FTSE Bursa Malaysia Hijrah Shariah Index Bursa 16,998.419 24.843 16.759 1.7789 2.698
FTSE Bursa Malaysia KLCI Index Bursa 33,179.717 25.377 18.089 1.6390 2.680
FTSE Bursa Malaysia Top 100 Index Bursa 13,559.990 32.372 21.003 1.5335 2.465
Local Peer TOPGLOV Bursa 31,778.032 18.132 3.707 4.6211 3.025
Local Peer SUPERMX Bursa 8,454.974 16.111 2.598 2.0386 -
Local Peer ADVENTA Bursa 262.792 - - 4.8533 -
Local Peer RGTBHD Bursa 234.996 47.244 17.392 2.2684 0.737
Local Peer LKL Bursa 153.030 - - 1.2833 -
Global Peer ABBOTT LABORATORIES NYSE 214,142.346 47.874 33.718 - 1.266
Global Peer DANAHER CORP NYSE 209,087.032 59.569 59.569 5.2949 0.245
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 207,624.902 32.569 26.202 5.9223 0.168
Global Peer MEDTRONIC PLC NYSE 175,405.828 48.643 48.643 3.4107 1.779
Global Peer INTUITIVE SURGICAL INC NASDAQ 115,482.430 108.884 71.171 10.6558 -
Global Peer STRYKER CORP NYSE 101,224.653 63.305 67.890 - 0.875
Global Peer BECTON DICKINSON & CO NYSE 73,716.800 96.111 44.949 2.9696 1.259
Global Peer EDWARDS LIFESCIENCES CORP NYSE 68,417.368 83.091 80.396 14.6868 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 64,551.941 - 218.081 - -
Global Peer IDEXX LABORATORIES INC NASDAQ 59,319.549 101.963 87.984 84.4171 -
Other Global Peers ALIGN TECHNOLOGY INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), DEXCOM INC (NASDAQ), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), ALCON AG (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), WATERS CORP (NYSE), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), COOPER COS INC (NYSE), PERKINELMER INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), NOVOCURE LTD (NASDAQ), INSULET CORPORATION (NASDAQ), TELEFLEX INC (NYSE), HOLOGIC INC (NASDAQ), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), MICROPORT-100 (HKEx), FISHER & PAYKEL HEALTHCARE CORP (ASX), BRUKER CORPORATION (NASDAQ), COCHLEAR LTD (ASX), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), ANGELALIGN (HKEx), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), WEIGAO GROUP (HKEx), Top Glove (SGX), ENVISTA HOLDINGS CORPORATION (NYSE), TANDEM DIABETES CARE INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), QUIDEL CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), NEVRO CORP (NYSE), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), NEOGEN CORP (NASDAQ), CAREDX INC (NASDAQ), INARI MEDICAL INC (NASDAQ), INMODE LTD (NASDAQ), ICU MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), CONMED CORP (NYSE), CARDIOFLOW-B (HKEx), ATRICURE INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), EBOS GROUP (ASX), NUVASIVE INC (NASDAQ), HAEMONETICS CORP (NYSE), AXONICS INC (NASDAQ), VENUS MEDTECH-B (HKEx), PEIJIA-B (HKEx), HESKA CORP (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), VERICEL CORP (NASDAQ), LIFETECH SCI (HKEx), GLAUKOS CORPORATION (NYSE), THE BEAUTY HEALTH COMPANY (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ZYLOXTB-B (HKEx), OUTSET MEDICAL INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), BUTTERFLY NETWORK INC (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), ESTABLISHMENT LABS HLDGS INC (NASDAQ), KANGJI MEDICAL (HKEx), INOGEN INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), SIGHT SCIENCES INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), PULMONX CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), AK MEDICAL (HKEx), NANO-X IMAGING LTD (NASDAQ), EARGO INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), NANOSONICS LIMITED (ASX), ATRION CORP (NASDAQ), CIRC (HKEx), VAREX IMAGING CORPORATION (NASDAQ), VIEWRAY INC (NASDAQ), CRYOLIFE INC (NYSE), ANGIODYNAMICS INC (NASDAQ), SI BONE INC (NASDAQ), BIOVENTUS INC (NASDAQ), DERMTECH INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CUTERA INC (NASDAQ), CHUNLI MEDICAL (HKEx), NATUS MEDICAL INC (NASDAQ), 908 DEVICES INC (NASDAQ), CERUS CORP (NASDAQ), MODERN DENTAL (HKEx), INFUSYSTEM HOLDINGS INC (NYSE American), AXOGEN INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), KDL MEDICAL (HKEx), NYXOAH SA (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), STEREOTAXIS INC (NYSE American), BASECARE-B (HKEx), VAPOTHERM INC (NYSE), TALIS BIOMEDICAL CORP (NASDAQ), ZYNEX INC (NASDAQ), PAVMED INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), NEUROPACE INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), ONCOCYTE CORP (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), SOLITON INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SIENTRA INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), ACCELERATE DIAGNOSTICS INC (NASDAQ), IRADIMED CORP (NASDAQ), MISONIX INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), LUCIRA HEALTH INC (NASDAQ), CVRX INC (NASDAQ), YESTAR HEALTH (HKEx), NEURONETICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), QUOTIENT LTD (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), Medtecs Intl (SGX), APYX MEDICAL CORPORATION (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), PROFOUND MED CORP (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), AROA BIOSURGERY LTD (ASX), CONFORMIS INC (NASDAQ), PW MEDTECH (HKEx), UGHealthcare (SGX), INVACARE CORP (NYSE), CORMEDIX INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), TELA BIO INC (NASDAQ), INTRICOM CORP (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), TITAN MEDICAL INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), MYMD PHARMACEUTICALS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), ALPHA PRO TECH (NYSE American), SOMNOMED LIMITED (ASX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), VENUS CONCEPT INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), KELFRED (HKEx), BIOSIG TECHNOLOGIES INC (NASDAQ), CYCLOPHARM LIMITED (ASX), FONAR CORP (NASDAQ), VINCENT MED (HKEx), IMPEDIMED LIMITED (ASX), CHECK-CAP LTD (NASDAQ), IRIDEX CORP (NASDAQ), MICRO-X LTD (ASX), NEUROMETRIX INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), ELECTROMED INC (NYSE American), CELSION CORPORATION (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), LENSAR INC (NASDAQ), AVINGER INC (NASDAQ), NEPHROS INC (NASDAQ), BIOLASE INC (NASDAQ), OPTISCAN IMAGING (ASX), ZOSANO PHARMA CORP (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), VOLITIONRX LIMITED (NYSE American), AETHLON MEDICAL INC (NASDAQ), APPLIED UV INC (NASDAQ), IMMUCELL CORP (NASDAQ), SDI LTD (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ELECTROCORE INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), EKSO BIONICS HOLDINGS INC (NASDAQ), YUNNAN ENERGY (HKEx), SENSUS HEALTHCARE INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEOVASC INC (NASDAQ), RESONANCE HEALTH LTD (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), COMPUMEDICS (ASX), Biolidics (SGX), STRATA SKIN SCIENCES INC (NASDAQ), CARDIEX LTD (ASX), NANOVIBRONIX INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), BIOMERICA INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), DIMERIX LTD (ASX), DAXOR CORP (NYSE American), RESPIRI LTD (ASX), Yunnan Energy (SGX), NOVA EYE MEDICAL LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), INSPIREMD INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), ADHERIUM LIMITED (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), DYNATRONICS CORP (NASDAQ), LBT INNOVATIONS LTD (ASX), PLUS THERAPEUTICS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), STAR EQUITY HOLDINGS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE American), LIFE HEALTHCARE (HKEx), CYANOTECH CORP (NASDAQ), USCOM LTD (ASX), METALICITY LIMITED (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), TRUSCREEN GROUP LTD (ASX), Annica (SGX), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.600
-7.74 %
10 Days --0.490
-6.41 %
20 Days -+0.010
+0.14 %
Medium Term Return 3 Months 0.177-3.250
-29.55 %
6 Months 0.274-5.050
-39.15 %
1 Year 0.333-13.130
-63.10 %
Long Term Return 2 Years 0.409+2.280
+55.22 %
3 Years 0.494+0.990
+24.09 %
5 Years 0.694+5.090
+280.78 %
Annualised Return Annualised --
+30.66 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 6.840 - 21.160 Change From 1 Year Low +0.310 % Change From 1 Year Low (%) +4.53
Change From 1 Year High -14.010 % Change From 1 Year High (%) -66.21
2 Years Range 4.800 - 21.160 Change From 2 Years Low +2.350 % Change From 2 Years Low (%) +48.96
Change From 2 Years High -14.010 % Change From 2 Years High (%) -66.21
5 Years Range 2.050 - 21.160 Change From 5 Years Low +5.100 % Change From 5 Years Low (%) +248.78
Change From 5 Years High -14.010 % Change From 5 Years High (%) -66.21
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Established in 1988, Hartalega began with this VISION to produce gloves that protect what matters most, LIFE.



From a humble beginning of a One-Line-Operation, Hartalega has experienced tremendous growth and evolved into a sizeable company of 43 Production Lines, with a capacity to produce over 8 billion gloves annually.



Since inception, every phase of our operation has been dedicated to a Tradition of Excellence.


IPO Performance

Listing Date 17 Apr 2008 Full Subscription Rate (x) -
No of Placement Shares (M) - No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (MYR) 1.800 First Day Close (MYR) 1.910 First Week Close (MYR) 1.790
Current vs IPO Price (%) +297.22 First Day Gain (%) +6.11 First Week Gain (%) -0.56

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Mar 2019 Part 1(2.69 MB)
Part 2(1.14 MB)
Annual Report 2018 Mar 2018 Part 1(2.47 MB)
Part 2(2.71 MB)
Part 3(0.68 MB)
Annual Report 2017 Mar 2017
Annual Report 2016 Mar 2016 Part 1(2.89 MB)
Part 2(2.90 MB)
Annual Report 2015 Mar 2015 Part 1(2.99 MB)
Annual Report 2014 Mar 2014 Part 1(2.06 MB)
Annual Report 2013 Mar 2013 Part 1(2.10 MB)
Annual Report 2012 Mar 2012 Part 1(2.28 MB)
Part 2(2.23 MB)
Annual Report 2011 Mar 2011 Part 1(0.12 MB)
Part 2(3.08 MB)
Part 3(2.85 MB)
Annual Report 2010 Mar 2010 Part 1(2.72 MB)
Annual Report 2009 Mar 2009 Part 1(2.24 MB)
Part 2(0.04 MB)
Annual Report 2008 Mar 2008 Part 1(0.85 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
29 Jul 2021 7.340 7.350 7.150 7.150 2,418,600 7.2129
28 Jul 2021 7.310 7.440 7.280 7.340 2,549,100 7.3425
27 Jul 2021 7.390 7.400 7.150 7.300 3,266,900 7.2739
26 Jul 2021 7.710 7.740 7.380 7.390 4,161,700 7.4784
23 Jul 2021 7.700 7.810 7.650 7.700 3,921,500 7.7186
22 Jul 2021 7.900 7.900 7.620 7.750 4,796,600 7.6992
21 Jul 2021 7.620 7.920 7.560 7.890 7,335,000 7.8021
19 Jul 2021 7.510 7.640 7.440 7.580 7,340,300 7.5439
16 Jul 2021 7.690 7.740 7.340 7.530 5,289,500 7.4566
15 Jul 2021 7.280 7.740 7.240 7.640 7,888,700 7.5232
14 Jul 2021 7.150 7.530 7.140 7.260 10,469,100 7.2902
13 Jul 2021 6.860 7.240 6.860 7.110 4,817,700 7.0895
12 Jul 2021 7.140 7.170 6.840 6.860 4,899,200 6.9447
09 Jul 2021 6.980 7.270 6.960 7.110 6,689,400 7.1502
08 Jul 2021 7.060 7.160 6.900 6.980 5,697,600 7.0307
07 Jul 2021 7.060 7.330 7.020 7.060 5,830,700 7.0913
06 Jul 2021 7.050 7.160 7.000 7.060 7,009,700 7.0619
05 Jul 2021 7.020 7.130 6.990 7.010 4,122,900 7.0088
02 Jul 2021 7.140 7.140 6.940 7.020 6,475,900 7.0155
01 Jul 2021 7.350 7.370 7.120 7.140 3,562,500 7.2150
30 Jun 2021 7.490 7.600 7.280 7.350 4,170,100 7.3751
29 Jun 2021 7.320 7.560 7.310 7.490 7,551,700 7.4560
Summary
Current 2 Weeks
(15 Jul 2021 to 29 Jul 2021)
7.280 7.920 7.150 7.150 48,967,900 -
Previous 2 Weeks
(01 Jul 2021 to 14 Jul 2021)
7.350 7.920 7.120 7.260 59,574,700 -
4 Weeks from
(02 Jun 2021 to 30 Jun 2021)
8.910 9.090 7.150 7.350 116,078,200 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.